Heart Health Supplement for High Cholesterol

Overseen By Matthew Amsden

Age: 18+

Sex: Any

Trial Phase: Phase 1

Sponsor: Efforia, Inc

Disqualifiers: Soy allergies, Liver disease, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 30

Duration: 12 weeks

60 Participants Needed

Trial Summary

What is the purpose of this trial?

We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor. The trial will assess changes in heart biomarkers such as Total Cholesterol, HDL-C, LDL-C, Triglycerides, and High-Sensitivity C-reactive protein (hs-CRP).

Eligibility Criteria

This trial is for individuals with high cholesterol levels. Participants should be willing to take a daily dose of a chocolate-flavored, powdered heart health supplement for three months and have their blood markers like total cholesterol and triglycerides monitored.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor, for 3 months

12 weeks

At-home blood collection at baseline, 30 days, and 90 days

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Heart Health Supplement

Trial Overview The study tests an experimental natural heart health supplement's effect on heart-related biomarkers over three months. It aims to see if the supplement can improve levels of good (HDL-C) and bad (LDL-C) cholesterol, triglycerides, and inflammation as measured by hs-CRP.

Participant Groups

Group I: Natural Heart Health Dietary Supplement in Chocolate Powder Form Experimental Treatment 1 Intervention

a natural heart-health dietary supplement in chocolate powder form designed to be taken daily.

Who Is Running the Clinical Trial?

Efforia, Inc

Lead Sponsor

Trials

3

Recruited

1,200+